Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Net Sales
3,201.15
3,062.61
3,233.98
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,201.15
3,062.61
3,233.98
Raw Material Cost
1,711.78
1,629.77
1,765.07
Purchase of Finished goods
138.08
161.98
196.04
(Increase) / Decrease In Stocks
3.21
2.60
19.82
Employee Cost
554.79
531.93
482.91
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
-3.87
272.54
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
423.00
369.64
377.59
Total Expenditure (Excl Depreciation)
2,830.85
2,692.05
3,113.97
Operating Profit (PBDIT) excl Other Income
370.30
370.56
120.01
Other Income
93.43
34.58
23.79
Operating Profit (PBDIT)
463.73
405.14
143.80
Interest
70.18
30.05
38.24
Exceptional Items
-18.23
8.48
-26.25
Gross Profit (PBDT)
375.32
383.57
79.31
Depreciation
114.43
113.45
91.69
Profit Before Tax
260.89
270.11
-12.39
Tax
85.83
75.95
-52.65
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
175.05
194.17
40.26
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
175.05
194.17
40.26
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-1.76
-1.35
-0.38
Other related items
0.00
0.00
0.00
Consolidated Net Profit
170.58
190.56
37.28
Equity Capital
30.62
30.62
28.61
Face Value
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
Diluted Earnings per share
4.33
4.26
13.21
Operating Profit Margin (Excl OI)
11.57%
12.1%
3.71%
Gross Profit Margin
11.72%
12.52%
2.45%
PAT Margin
5.47%
6.34%
1.24%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 4.52% vs -5.30% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is -10.48% vs 411.16% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is -0.07% vs 208.77% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 133.54% vs -21.42% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
Compare Nine Monthly Results Of Akums Drugs With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
3,201.15
459.92
2,741.23
596.02%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,201.15
459.92
2,741.23
596.02%
Raw Material Cost
1,711.78
198.36
1,513.42
762.97%
Purchase of Finished goods
138.08
0.00
138.08
(Increase) / Decrease In Stocks
3.21
-34.92
38.13
109.19%
Employee Cost
554.79
41.37
513.42
1,241.04%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.01
-0.02
-200.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
423.00
95.80
327.20
341.54%
Total Expenditure (Excl Depreciation)
2,830.85
300.62
2,530.23
841.67%
Operating Profit (PBDIT) excl Other Income
370.30
159.30
211.00
132.45%
Other Income
93.43
22.16
71.27
321.62%
Operating Profit (PBDIT)
463.73
181.46
282.27
155.55%
Interest
70.18
5.16
65.02
1,260.08%
Exceptional Items
-18.23
0.00
-18.23
Gross Profit (PBDT)
375.32
176.30
199.02
112.89%
Depreciation
114.43
10.92
103.51
947.89%
Profit Before Tax
260.89
165.39
95.50
57.74%
Tax
85.83
39.64
46.19
116.52%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
175.05
125.75
49.30
39.20%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
175.05
125.75
49.30
39.20%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-1.76
-1.25
-0.51
-40.80%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
170.58
124.01
46.57
37.55%
Equity Capital
30.62
11.29
19.33
171.21%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
11.72%
38.33%
0.00
-26.61%
PAT Margin
5.47%
27.34%
0.00
-21.87%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 3,201.15 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 4.52% vs -5.30% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 170.58 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -10.48% vs 411.16% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 370.30 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -0.07% vs 208.77% in Dec 2024
Nine Monthly - Interest
Interest 70.18 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 133.54% vs -21.42% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.57%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
